// App-Quantinova.ai

34 : The Clinical Implications of Cardiac Troponin I Measured by an Ultrasensitive Assay in Acute Decompensated Heart Failure: Insights from ASCEND-HF

Researchers

Presenter

  • Justin L. Grodin

Principal Investigators

  • Adrian F. Hernandez

  • Javed Butler

  • Marco Metra

  • G. Michael Felker

  • Adrian Voors

  • John J. McMurray

  • Paul W. Armstrong

  • Randall C. Starling

  • Christopher -Connor

  • W. H. Wilson Tang

Medical Centers

  • University of Brescia, Brescia, Italy

  • University of Groningen, Groningen, Netherlands

  • Duke University Medical Center, Durham, NC

  • University of Glasgow, Glasgow, United Kingdom

  • Stony Brook University, Stony Brook, NY

  • Cleveland Clinic, Cleveland, OH

Locations

  • United States

  • United Kingdom

  • Italy

  • Netherlands

Companies

  • N/A

Study Components

Therapeutic Area

  • Genetic Disorder

  • Endocrine/metabolic Diseases (ME)

Disease

  • Acute decompensated heart failure

  • Acute Coronary Syndromes

  • Congestive heart failure

  • Dyspnea

  • Cystinosis, nephropathic type

Biomarkers

  • Troponin I

  • N-terminal pro b-type natriuretic peptide

Drug/Treatment

  • Nesiritide

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final